Abstract
Satralizumab (Enspryng(R)), a humanized anti-interleukin-6 (IL-6) receptor monoclonal recycling antibody, has been developed by Chugai Pharmaceutical ......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
